Orsini, S.I.; Marrani, E.; Pagnini, I.; Taccetti, G.; Terlizzi, V.; Simonini, G.
Concomitant Use of Elexacaftor/Tezacaftor/Ivacaftor and Etanercept in a Cystic Fibrosis Patient with Juvenile Idiopathic Arthritis. J. Clin. Med. 2023, 12, 1730.
https://doi.org/10.3390/jcm12051730
AMA Style
Orsini SI, Marrani E, Pagnini I, Taccetti G, Terlizzi V, Simonini G.
Concomitant Use of Elexacaftor/Tezacaftor/Ivacaftor and Etanercept in a Cystic Fibrosis Patient with Juvenile Idiopathic Arthritis. Journal of Clinical Medicine. 2023; 12(5):1730.
https://doi.org/10.3390/jcm12051730
Chicago/Turabian Style
Orsini, Sara Immacolata, Edoardo Marrani, Ilaria Pagnini, Giovanni Taccetti, Vito Terlizzi, and Gabriele Simonini.
2023. "Concomitant Use of Elexacaftor/Tezacaftor/Ivacaftor and Etanercept in a Cystic Fibrosis Patient with Juvenile Idiopathic Arthritis" Journal of Clinical Medicine 12, no. 5: 1730.
https://doi.org/10.3390/jcm12051730
APA Style
Orsini, S. I., Marrani, E., Pagnini, I., Taccetti, G., Terlizzi, V., & Simonini, G.
(2023). Concomitant Use of Elexacaftor/Tezacaftor/Ivacaftor and Etanercept in a Cystic Fibrosis Patient with Juvenile Idiopathic Arthritis. Journal of Clinical Medicine, 12(5), 1730.
https://doi.org/10.3390/jcm12051730